Grill Joshua

Title(s)Adjunct Instructor, Neurology
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Effects of Alzheimers Disease Clinical Trial Study Partners-Diversity Supplement
    NIH/NIA RF1AG059407May 15, 2018 - Apr 30, 2022
    Role: Principal Investigator
    Effects of Alzheimer's disease clinical trial study partners
    NIH/NIA R01AG059407May 15, 2018 - Feb 28, 2022
    Role: Principal Investigator
    The study partner requirement in preclinical Alzheimers disease trials
    NIH/NIA R21AG056931Sep 15, 2017 - May 31, 2019
    Role: Principal Investigator
    UCLA NEXT Collaboration Site
    NIH/NINDS U10NS077355Sep 30, 2011 - Aug 31, 2018
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Grill JD, Cox CG, Harkins K, Karlawish J. Reactions to learning a "not elevated" amyloid PET result in a preclinical Alzheimer's disease trial. Alzheimers Res Ther. 2018 Dec 22; 10(1):125. PMID: 30579361.
      View in: PubMed
    2. Cox CG, Ryan B A MM, Gillen DL, Grill JD. A Preliminary Study of Clinical Trial Enrollment Decisions Among People With Mild Cognitive Impairment and Their Study Partners. Am J Geriatr Psychiatry. 2019 Mar; 27(3):322-332. PMID: 30522811.
      View in: PubMed
    3. Pierce AL, Cox CG, Nguyen HT, Hoang D, Witbracht M, Gillen DL, Grill JD. Participant Satisfaction With Learning Alzheimer Disease Clinical Trial Results. Alzheimer Dis Assoc Disord. 2018 Oct-Dec; 32(4):366-368. PMID: 29683808.
      View in: PubMed
    4. Largent EA, Karlawish J, Grill JD. Study partners: essential collaborators in discovering treatments for Alzheimer's disease. Alzheimers Res Ther. 2018 Sep 27; 10(1):101. PMID: 30261910.
      View in: PubMed
    5. Torosyan N, Sethanandha C, Grill JD, Dilley ML, Lee J, Cummings JL, Ossinalde C, Silverman DH. Changes in regional cerebral blood flow associated with a 45?day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study. Exp Gerontol. 2018 Oct 01; 111:118-121. PMID: 30006299.
      View in: PubMed
    6. Grill JD, Hoang D, Gillen DL, Cox CG, Gombosev A, Klein K, O'Leary S, Witbracht M, Pierce A. Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment. J Alzheimers Dis. 2018; 63(3):1055-1063. PMID: 29710723.
      View in: PubMed
    7. Grill JD, Karlawish J. Study partners should be required in preclinical Alzheimer's disease trials. Alzheimers Res Ther. 2017 Dec 06; 9(1):93. PMID: 29212555.
      View in: PubMed
    8. Nuño MM, Gillen DL, Dosanjh KK, Brook J, Elashoff D, Ringman JM, Grill JD. Attitudes toward clinical trials across the Alzheimer's disease spectrum. Alzheimers Res Ther. 2017 Oct 04; 9(1):81. PMID: 28978335.
      View in: PubMed
    9. Grill JD. Recruiting to preclinical Alzheimer's disease clinical trials through registries. Alzheimers Dement (N Y). 2017 Jun; 3(2):205-212. PMID: 28439532.
      View in: PubMed
    10. Grill JD, Apostolova LG, Bullain S, Burns JM, Cox CG, Dick M, Hartley D, Kawas C, Kremen S, Lingler J, Lopez OL, Mapstone M, Pierce A, Rabinovici G, Roberts JS, Sajjadi SA, Teng E, Karlawish J. Communicating mild cognitive impairment diagnoses with and without amyloid imaging. Alzheimers Res Ther. 2017 May 04; 9(1):35. PMID: 28472970.
      View in: PubMed
    11. Boise L, Hinton L, Rosen HJ, Ruhl MC, Dodge H, Mattek N, Albert M, Denny A, Grill JD, Hughes T, Lingler JH, Morhardt D, Parfitt F, Peterson-Hazan S, Pop V, Rose T, Shah RC. Willingness to Be a Brain Donor: A Survey of Research Volunteers From 4 Racial/Ethnic Groups. Alzheimer Dis Assoc Disord. 2017 Apr-Jun; 31(2):135-140. PMID: 27779492.
      View in: PubMed
    12. Grill JD, Cox CG, Kremen S, Mendez MF, Teng E, Shapira J, Ringman JM, Apostolova LG. Patient and caregiver reactions to clinical amyloid imaging. Alzheimers Dement. 2017 Aug; 13(8):924-932. PMID: 28174068.
      View in: PubMed
    13. Grill JD, Holbrook A, Pierce A, Hoang D, Gillen DL. Attitudes toward Potential Participant Registries. J Alzheimers Dis. 2017; 56(3):939-946. PMID: 28106553.
      View in: PubMed
    14. Chang TS, Teng E, Elashoff D, Grill JD. Optimizing Effect Sizes With Imaging Enrichment and Outcome Choices for Mild Alzheimer Disease Clinical Trials. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):19-26. PMID: 27196535.
      View in: PubMed
    15. Apostolova LG, Haider JM, Goukasian N, Rabinovici GD, Chételat G, Ringman JM, Kremen S, Grill JD, Restrepo L, Mendez MF, Silverman DH. Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care. Alzheimers Dement (Amst). 2016; 5:15-22. PMID: 28054024.
      View in: PubMed
    16. Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD. African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials. Alzheimers Dement (N Y). 2017 Jan; 3(1):57-64. PMID: 29067319.
      View in: PubMed
    17. Lin A, Brook J, Grill JD, Teng E. Participant-Informant Relationships Affect Quality of Life Ratings in Incipient and Clinical Alzheimer Disease. Am J Geriatr Psychiatry. 2017 Mar; 25(3):297-307. PMID: 27818119.
      View in: PubMed
    18. Grill JD, Zhou Y, Elashoff D, Karlawish J. Disclosure of amyloid status is not a barrier to recruitment in preclinical Alzheimer's disease clinical trials. Neurobiol Aging. 2016 Mar; 39:147-53. PMID: 26923411; PMCID: PMC4773920 [Available on 03/01/17].
    19. Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Pilcher G, Ferris S, Colby S, Kerselaers W, Dockens R, Soares H, Kaplita S, Luo F, Pachai C, Bracoud L, Mintun M, Grill JD, Marek K, Seibyl J, Cedarbaum JM, Albright C, Feldman HH, Berman RM. Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. JAMA Neurol. 2015 Nov; 72(11):1324-33. PMID: 26414022.
      View in: PubMed
    20. Grill JD, Karlawish J. Consider the Source: The Implications of Informant Type on Outcome Assessments. Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):364. PMID: 26485500; PMCID: PMC4648644 [Available on 10/01/16].
    21. Grill JD, Vinters HV, Monsell SE. Does Alzheimer Disease Pathologic Change Underlie Subjective Cognitive Complaints? Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):350-2. PMID: 25973910; PMCID: PMC4643424 [Available on 10/01/16].
    22. Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):50. PMID: 26203303; PMCID: PMC4511231.
    23. Grill JD, Zhou Y, Karlawish J, Elashoff D. Frequency and impact of informant replacement in Alzheimer disease research. Alzheimer Dis Assoc Disord. 2015 Jul-Sep; 29(3):242-8. PMID: 25551863; PMCID: PMC4486637.
    24. Grill JD, Raman R, Ernstrom K, Aisen P, Dowsett SA, Chen YF, Liu-Seifert H, Hake AM, Miller DS, Doody RS, Henley DB, Cummings JL. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials. Alzheimers Res Ther. 2015; 7(1):39. PMID: 26120368; PMCID: PMC4481112.
    25. Henley DB, Dowsett SA, Chen YF, Liu-Seifert H, Grill JD, Doody RS, Aisen P, Raman R, Miller DS, Hake AM, Cummings J. Alzheimer's disease progression by geographical region in a clinical trial setting. Alzheimers Res Ther. 2015; 7(1):43. PMID: 26120369.
      View in: PubMed
    26. Harkins K, Sankar P, Sperling R, Grill JD, Green RC, Johnson KA, Healy M, Karlawish J. Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants. Alzheimers Res Ther. 2015; 7(1):26. PMID: 25969699; PMCID: PMC4428104.
    27. Jennings LA, Reuben DB, Evertson LC, Serrano KS, Ercoli L, Grill J, Chodosh J, Tan Z, Wenger NS. Unmet needs of caregivers of individuals referred to a dementia care program. J Am Geriatr Soc. 2015 Feb; 63(2):282-9. PMID: 25688604; PMCID: PMC4332558.
    28. Cary MS, Rubright JD, Grill JD, Karlawish J. Why are spousal caregivers more prevalent than nonspousal caregivers as study partners in AD dementia clinical trials? Alzheimer Dis Assoc Disord. 2015 Jan-Mar; 29(1):70-4. PMID: 24805971; PMCID: PMC4223007.
    29. Hsiao JJ, Lu PH, Grill JD, Teng E. Longitudinal declines in instrumental activities of daily living in stable and progressive mild cognitive impairment. Dement Geriatr Cogn Disord. 2015; 39(1-2):12-24. PMID: 25300404; PMCID: PMC4312538.
    30. Grill JD, Zhou Y, Karlawish J, Elashoff D. Does study partner type impact the rate of Alzheimer's disease progression? J Alzheimers Dis. 2014; 38(3):507-14. PMID: 23985417; PMCID: PMC3842422.
    31. Grill JD, Monsell SE. Choosing Alzheimer's disease prevention clinical trial populations. Neurobiol Aging. 2014 Mar; 35(3):466-71. PMID: 24119546; PMCID: PMC3864603.
    32. Hooper M, Grill JD, Rodriguez-Agudelo Y, Medina LD, Fox M, Alvarez-Retuerto AI, Wharton D, Brook J, Ringman JM. The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemp Clin Trials. 2013 Sep; 36(1):256-62. PMID: 23876673; PMCID: PMC3858206.
    33. Kohannim O, Hua X, Rajagopalan P, Hibar DP, Jahanshad N, Grill JD, Apostolova LG, Toga AW, Jack CR, Weiner MW, Thompson PM. Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin. 2013; 2:827-35. PMID: 24179834; PMCID: PMC3777716.
    34. Grill JD, Raman R, Ernstrom K, Aisen P, Karlawish J. Effect of study partner on the conduct of Alzheimer disease clinical trials. Neurology. 2013 Jan 15; 80(3):282-8. PMID: 23255824; PMCID: PMC3589183.
    35. Grill JD, Karlawish J, Elashoff D, Vickrey BG. Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment. Alzheimers Dement. 2013 May; 9(3):356-359.e1. PMID: 23141383; PMCID: PMC3572336.
    36. Grill JD, Monsell S, Karlawish J. Are patients whose study partners are spouses more likely to be eligible for Alzheimer's disease clinical trials? Dement Geriatr Cogn Disord. 2012; 33(5):334-40. PMID: 22759982.
      View in: PubMed
    37. Grill JD, Di L, Lu PH, Lee C, Ringman J, Apostolova LG, Chow N, Kohannim O, Cummings JL, Thompson PM, Elashoff D. Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging. 2013 Jan; 34(1):62-72. PMID: 22503160; PMCID: PMC3412892.
    38. Grill JD, Ringman JM. Should persons with autosomal dominant AD be included in clinical trials? Alzheimers Res Ther. 2011 May 23; 3(3):18. PMID: 21609419; PMCID: PMC3226307.
    39. Grill JD, Karlawish J. Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther. 2010 Dec 21; 2(6):34. PMID: 21172069; PMCID: PMC3031880.
    40. Grill JD, Cummings JL. Current therapeutic targets for the treatment of Alzheimer's disease. Expert Rev Neurother. 2010 May; 10(5):711-28. PMID: 20420492; PMCID: PMC4140224.
    41. Ringman JM, Grill J, Rodriguez-Agudelo Y, Chavez M, Xiong C. Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges. Alzheimers Dement. 2009 Mar; 5(2):166-71. PMID: 19328453; PMCID: PMC2746429.